87  Total SME IPOs listed in 2025

3,963.65 Crs.  Total funds raised in 2025

60  SME IPOs listed with Gain in 2025

27  SME IPOs listed with loss in 2025

87  Total SME IPOs listed in 2025

3963.65 Crs.  Total funds raised in 2025

60  SME IPOs listed with Gain in 2025

27  SME IPOs listed with loss in 2025

87  Total SME IPOs listed in 2025

3963.65 Crs.  Total funds raised in 2025

60  SME IPOs listed with Gain in 2025

27  SME IPOs listed with loss in 2025

87  Total SME IPOs listed in 2025

3963.65 Crs.  Total funds raised in 2025

60  SME IPOs listed with Gain in 2025

27  SME IPOs listed with loss in 2025

Nirman Agri Genetics Limited IPO Analysis

Nirman Agri Genetics IPO is a Fixed Price listing on NSE EMERGE exchange, with an ipo size of ₹ 20.30 Cr. The company is based in Nashik and caters to Chemical - Pesticides sector. First Overseas Capital is the merchant banker of Nirman Agri Genetics IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 17th January 2023.

Nirman Agri Genetics IPO posted revenues of ₹ 30.93 crores and PAT of ₹ 3.94 crores in FY23 on annualised basis.

IPO Key Highlights

*At the time of IPO, on Annualised Basis
  • Revenue: ₹ 30.93 Cr.
            EBITDA: ₹ 5.35 Cr.
            PAT: ₹ 3.94 Cr.
  • EBITDA Margin: 17.29 %
            Pat Margin: 12.75 %
  • Net Worth: ₹ 4.47 Cr.
  • Market Capitalisation: ₹ 59.01 Cr.
  • P/E: 14.93 times
  • P/BV: 2.38 times
  • EV/EBITDA: 11.26 times
Nature of IPO : SME
Exchange : NSE EMERGE
IPO Type : Fixed Price

Nirman Agri IPO Financial Performance (Restated)

Financial results of Nirman Agri Genetics IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.

Amount in ₹ crores
Financials Oct-22 FY22 FY21 FY20
Balance Sheet
Assets 9.15 5.95 1.64 [●]
Net Worth 4.47 2.64 6.47 [●]
Total Debt 1.71 1.24 0.99 [●]
Profit & Loss
Revenue
Revenue on annualised basis
18.04
30.93
13.48 3.82 [●]
EBITDA
EBITDA on annualised basis
3.12
5.35
3.42 0.07 [●]
PAT
PAT on annualised basis
2.30
3.94
2.56 0.05 [●]
Financials
30-Oct-22
FY22
FY21
FY20
Balance Sheet
Assets
9.15
5.95
1.64
[●]

Net Worth
4.47
2.64
6.47
[●]

Total Debt
1.71
1.24
0.99
0.00

Profit & Loss
Revenue
Revenue on annualised basis
18.04
30.93
13.48
3.82
[●]

EBITDA
EBITDA on annualised basis
3.12
5.35
3.42
0.07
[●]

PAT
PAT on annualised basis
2.30
3.94
2.56
0.05
[●]

Notes:
1) Total debt incluides long-term borrowings and short-term borrowings.
2) Revenue means the Revenue from Operations as appearing in the Restated Financial Statements.

Nirman Agri IPO Key performance Indicators (KPI)

Nirman Agri Genetics IPO PAT Margin is 12.75 % , ROCE (Return on Capital Employed) is 1.17 % as per latest financial. The below table shows Nirman Agri Genetics IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.

Particulars Oct-22 FY22 FY21 FY20
EBITDA Margin (%) 17.29 25.37 1.83 [●]
PAT Margin (%) 12.75 18.99 1.31 [●]
EPS (₹) 9.00 10.00 0.21 [●]
ROE (%) 51.45 96.97 0.77 [●]
ROCE (%) 1.17 21.20 8.33 6.31
ROA (%) 25.14 43.03 3.05 [●]
Debt to Equity 0.38 0.47 0.15 [●]
Particulars
30-Oct-22
FY22
FY21
FY20

EBITDA Margin (%)
17.29
25.37
1.83
[●]

PAT Margin (%)
12.75
18.99
1.31
[●]

EPS (₹)
9.00
10.00
0.21
[●]

ROE (%)
51.45
96.97
0.77
[●]

ROCE (%)
1.17
21.20
8.33
6.31

ROA (%)
25.14
43.03
3.05
[●]

Debt to Equity (x)  
0.38
0.47
0.15
[●]

Notes:
1) The EPS represents post-bonus basic EPS.
2) Return on Equity is ratio of Profit after Tax and Total Equity.
3) Return on Assets is ratio of Profit after Tax and Total Assets.
4) Debt to Equity is ratio of Total borrowings and Total Equity.

Nirman Agri Genetics IPO Valuation Metrics

The market Capitalisation of Nirman Agri Genetics IPO is ₹ 59.01 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.

Key Metrics (at the time of IPO)


Market Capitalisation (₹ Cr.):
59.01

Enterprise Value (EV) (₹ Cr.):
60.22

EV/EBITDA (times) :
11.26

PE Multiple (times) :
14.93

P/B (times) :
2.38

NAV (₹) :
17.48

Notes:
1) The Enterprise Value is calculated as Market Cap. + Total Debt - Cash and Cash Equivalents.
2) Price to Book multiple is calculated as the ratio of Market Cap. and Net Worth post IPO proceeds.

What are the key financial metrics in Nirman Agri prospectus?

The Nirman Agri Genetics IPO prospectus highlights an Return on Equity (ROE) of 51.45 % , Return on Assets (ROA) of 25.14 %, and an EBITDA Margin of 17.29 %, showcasing financial performance.

How do profitability ratios impact the evaluation of Nirman Agri IPO?

Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Nirman Agri Genetics IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.

What is the market capitalisation for Nirman Agri IPO ?

The post-IPO market capitalisation of Nirman Agri Genetics IPO is ₹ 59.01 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.

What is the PE Multiple of Nirman Agri IPO?

The Nirman Agri Genetics IPO has a Price-to-Earnings (PE) ratio of 14.93 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.

What is the Revenue of Nirman Agri Genetics IPO?

Nirman Agri Genetics IPO reported revenue of ₹ 30.93 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Nirman Agri Genetics IPO provide insights into sales growth, market demand, and business scalability.

What is the EBITDA of Nirman Agri Genetics IPO?

Nirman Agri Genetics recorded an EBITDA of ₹ 5.35 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.

What is the PAT of Nirman Agri Genetics IPO?

Nirman Agri Genetics Profit After Tax (PAT) is ₹ 3.94 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions

IPO Key Highlights

*At the time of IPO, on Annualised Basis
  • Revenue: ₹ 30.93 Cr.
            EBITDA: ₹ 5.35 Cr.
            PAT: ₹ 3.94 Cr.
  • EBITDA Margin: 17.29 %
            Pat Margin: 12.75 %
  • Net Worth: ₹ 4.47 Cr.
  • Market Capitalisation: ₹ 59.01 Cr.
  • P/E: 14.93 times
  • P/BV: 2.38 times
  • EV/EBITDA: 11.26 times

Revenue

(As Annualised)

EBITDA

(As Annualised)

PAT

(As Annualised)
Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

Recent IPO List


Safe Enterprises Retail Fixtures Limited

  Corporate Solutions

  Mumbai


Mayasheel Ventures Limited

  Infrastructure

  New Delhi


Influx Healthtech Limited

  Healthcare

  Mumbai


Eppeltone Engineers Limited

  Engineering

  New Delhi


Peer Companies Of This Sector

FAQs

Nirman Agri Genetics operates in Chemical - Pesticides and Production Of Hybrid Seeds. The Issue is listed on NSE EMERGE in Mar, 2023. Nirman Agri Genetics IPO size was 20.30 with Issue price of 99.00 .

Nirman Agri Genetics IPO subscription was 1.71 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Nirman Agri Genetics IPO listed at a listing price of 102.00 against the offer price of 99.00.

The current market price of Nirman Agri Genetics is 196.55.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency